This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Medtronic PLC (MDT) shed 1.79% to $87.38 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&amp;P 500 Index falling 1.52% to 6,672.62 and Dow Jones Industrial Average falling 1.56% to 46,677.85.
This was the stock's third consecutive day of losses.
Medtronic PLC closed 17.82% below its 52-week high of $106.33, which the company reached on November 26th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson &amp; Johnson (JNJ) fell 0.39% to $242.04, Danaher Corp. (DHR) fell 4.51% to $186.26, and Abbott Laboratories (ABT) fell 1.91% to $108.14.
Trading volume (11.0 M) eclipsed its 50-day average volume of 8.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled March 12, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
03-12-26 1639ET

Medtronic PLC (MDT) shares fell 1.79% to $87.38 on Thursday, marking the third consecutive day of losses amid a declining stock market. The S&P 500 and Dow Jones also experienced declines of 1.52% and 1.56%, respectively. Medtronic's stock is now 17.82% below its 52-week high of $106.33. In comparison, competitors like Johnson & Johnson, Danaher Corp., and Abbott Laboratories also saw declines in their stock prices. Trading volume for Medtronic was 11.0 million, surpassing its 50-day average of 8.3 million.

Dow Jones

Medtronic

Abbott Laboratories

Johnson & Johnson

SPDR S&P Health Equip

VanEck Biotech ETF

ALPS Medical Breakthrough

iShares US Pharma

Health Care Select Sector SPDR

iShares US Medical Devices

Invesco Biotechnology & Genome ETF

VG Health

Danaher

iShares Biotechnology ETF

iShares Global Healthcare

SPDR S&P Biotech

Direxion S&P Biotech Bull 3X

Medtronic PLC Stock Underperforms Thursday When Compared To Competitors